Dysregulation of insulin-regulated pathways culminates in and sustains the pathophysiological alterations found in metabolic syndrome, such as reduced endothelial function, mitochondrial dysfunction, and inhibited glycolytic processes, which are changes observed early in the course of the development of T2DM.18 Here, INS is linked to metabolic syndrome.